In this study, the oral administration of CD alleviated the characteristics of psoriasis in the IMQ-induced mice model and CD decreased the activation of keratinocytes via the inhibition of pro-inflammatory cytokine production by suppressing the activity of STAT1 and the NF-κB pathways. Here, NFKB1 is linked to psoriasis.